BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17275315)

  • 21. A stable fish reporter cell line to study estrogen receptor transactivation by environmental (xeno)estrogens.
    Cosnefroy A; Brion F; Guillet B; Laville N; Porcher JM; Balaguer P; Aït-Aïssa S
    Toxicol In Vitro; 2009 Dec; 23(8):1450-4. PubMed ID: 19591918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
    Lam HY; Ng PK; Goldenberg GJ; Wong CM
    Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
    Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
    Gust R; Niebler K; Schönenberger H
    J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells.
    Laïos I; Cleeren A; Leclercq G; Nonclercq D; Laurent G; Schlenk M; Wellner A; Gust R
    Biochem Pharmacol; 2007 Oct; 74(7):1029-38. PubMed ID: 17706611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
    Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells.
    Yuri T; Tsukamoto R; Miki K; Uehara N; Matsuoka Y; Tsubura A
    Oncol Rep; 2006 Dec; 16(6):1307-12. PubMed ID: 17089054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
    Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
    Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
    Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
    Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.
    Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH
    Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y; Zhou Q; Hang Y; Bu X; Jia W
    Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
    Liu J; Sidell N
    Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR
    Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
    Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
    Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of estrogen receptor in the regulation of estrogen induced amino acid transport of System A in breast cancer and other receptor positive tumor cells.
    Bhat HK; Vadgama JV
    Int J Mol Med; 2002 Mar; 9(3):271-9. PubMed ID: 11836633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of C2-alkylation, N-alkylation, and N,N'-dialkylation on the stability and estrogen receptor interaction of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
    von Rauch M; Schlenk M; Gust R
    J Med Chem; 2004 Feb; 47(4):915-27. PubMed ID: 14761193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells.
    Kang SC; Lee BM
    J Toxicol Environ Health A; 2005 Nov; 68(21):1833-40. PubMed ID: 16207632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.